Edgewell Personal Care (NYSE:EPC) Misses Q2 CY2026 Revenue Estimates

Edgewell Personal Care (NYSE: EPC) reported Q2 CY2026 revenue of $570.1 million, up 1.7% year on year but below Wall Street estimates. Non-GAAP EPS was $0.72, 17.6% above consensus. The company cited improving organic net sales and North America performance. Shares were flat at $28.57 after the report.

Original reporting
Published Aug 5, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 12:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Edgewell Personal Care (NYSE:EPC) Misses Q2 CY2026 Revenue Estimates — source image
Decision brief

The 30-second read

$EPCNeutralMed
01

Why it matters

Traders should weigh the revenue and gross margin miss against the EPS and adjusted EBITDA outperformance, plus the modest organic growth turnaround after a prolonged period of organic declines.

02

Market read

This is a mixed earnings-style update: revenue and gross margin missed, while EPS and adjusted EBITDA beat, and organic sales showed a small YoY rebound.

03

What to watch

The article notes organic sales declined on average over eight quarters and gross margin fell short, which could outweigh the EPS beat for longer-term demand and pricing assumptions.

Relevance 6/10Novelty 6/10Timing: post-Q2 results, immediately after reporting

Background

Edgewell is a personal care company with brands including Banana Boat, Schick, and Skintimate, and it reported Q2 CY2026 results versus Wall Street expectations.

Company-level read

Ticker impact

$EPCNeutralMedium confidence
Context

Edgewell (EPC) reported Q2 CY2026 revenue of $570.1M, up 1.7% YoY, but below Wall Street estimates.

Expected impact

Likely choppy trading, with downside risk if investors focus on organic demand softness and gross margin weakness.

Evidence & confidence

The article provides directionally conflicting signals: EPS beat and EBITDA outperformance versus revenue miss and gross margin shortfall, plus organic sales only modestly positive after eight quarters of decline.

Market effects

Signals ongoing demand and margin pressure in consumer/personal care, even when earnings can be supported by cost control.

No specific regional read-through provided beyond management commentary on North America improvement.

No explicit global macro or international catalyst described.

Counterpoint

Investors may look past the revenue miss because organic sales turned positive YoY in the quarter and management cited progress toward fiscal 2026 targets.

Key entities

  • Edgewell Personal Care

    Reported Q2 CY2026 revenue and profitability results versus consensus, including organic sales and margin commentary.

  • Rod Little

    CEO who said Q3 results represent progress toward fiscal 2026 progression, with organic net sales returning to growth.

Related articles

$EPCMed

Edgewell’s (EPC) Margins Slip Even As North America Rebounds

Edgewell Personal Care (EPC) reported Q3 2026 results with net sales up 1.7% to $570.1M, driven by North America's 3.0% organic growth. However, operating income fell 44% due to margin declines and higher costs. Adjusted EPS held at $0.72, matching prior year. CEO Rod Little called it an 'important step forward.'

$EPCMed

How Edgewell’s Revenue Miss and Margin Pressure Will Impact Edgewell Personal Care (EPC) Investors

Edgewell Personal Care (EPC) reported Q2 revenue up 1.7% YoY but missed estimates, with organic revenue and EBITDA also below forecasts. Management highlighted adjusted EPS and EBITDA beating expectations, but weaker margins and EPS momentum raised concerns. The company affirmed its dividend while lowering full-year EPS guidance, focusing on cash generation amid profitability scrutiny. Analysts project $2.0B revenue and $769.1M earnings by 2029, with a 11% upside to current price.

$EPCMedAI 8/10

Edgewell (EPC) Q3 2026 Earnings Call Transcript

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% reported and 1.1% organic, with North America organic growth of 3.0% and international down 1.4% due to Middle East and supply disruptions. Adjusted EPS was $0.72. Full-year guidance: organic net sales flat to 0.5%, adjusted EPS $1.80-$2.00, EBITDA $250-$260 million.

$EPCMedAI 8/10

Edgewell (EPC) Q3 2026 Earnings Call Transcript

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% on a 1.1% organic increase. Adjusted EPS was $0.72, flat year over year. Adjusted EBITDA fell to $78.9 million. Management cited North America organic growth of 3.0% and a 1.4% international decline from Middle East and supply disruptions. Full-year organic sales guidance is flat to +0.5%, adjusted EPS $1.80-$2.00.